Monitoring Population Levels of Alcohol Consumption in Pregnant Women: A Case for Using Biomarkers

Deborah Shipton*, David Tappin, Roy Sherwood, Helen Mactier, David Aitken, Jenny Crossley

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)

    Abstract

    A challenge to biochemically monitoring alcohol consumption in pregnancy is the prohibitive costs of collecting thousands of blood samples. This pilot study looks at the feasibility of using residual samples to monitor chronic and acute alcohol consumption in pregnancy. Residual anomalies screening samples (n = 150, 2006/7) were tested for carbohydrate-deficient transferrin (CDT, chronic marker) and ethyl glucuronide (EtG, acute marker). Valid readings were obtained for CDT but not EtG. These results pave the way for a larger representative study, to provide, for the first time, a national biochemical baseline estimate of chronic alcohol consumption in the pregnant population.

    Original languageEnglish
    Pages (from-to)569-573
    Number of pages5
    JournalSubstance Use and Misuse
    Volume48
    Issue number8
    DOIs
    Publication statusPublished - Jun 2013

    Keywords

    • alcohol consumption
    • pregnancy
    • biomarkers
    • monitoring
    • baseline
    • CARBOHYDRATE-DEFICIENT TRANSFERRIN
    • ETHYL GLUCURONIDE
    • UNITED-STATES
    • DRINKING
    • OPPORTUNITIES
    • CARE

    Fingerprint

    Dive into the research topics of 'Monitoring Population Levels of Alcohol Consumption in Pregnant Women: A Case for Using Biomarkers'. Together they form a unique fingerprint.

    Cite this